Acquisition announced

Article

Optos plc has announced its proposed acquisition of the entire issued shared capital of Opto Global Holdings for up to $14.75 million.

Optos plc has announced its proposed acquisition of the entire issued shared capital of Opto Global Holdings for up to $14.75 million.

This transaction will afford Optos a strong product range in glaucoma, retina, cataract & refractive treatment and diagnosis, and a global distribution network. Additionally, the company will be able to expand Opto Global's products into the US and EU markets as well as promoting its own products in the Far and Middle East, Australasia, Africa and Latin America.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.